Fertiga is a company headquartered in Belgium.
Fertiga develops the Aurora niPCT™, a non-invasive molecular diagnostic test analyzing cumulus cells removed during ICSI to accurately rank egg quality and improve embryo selection in IVF treatments, increasing pregnancy and live birth rates.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.